NDDS in Cancer Therapy

Global Market Trajectory & Analytics

MCP15942

EXECUTIVE ENGAGEMENTS

OUTREACH

647
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

129
Interactions with Platform & by Email

PARTICIPANTS

26
Unique # Participated

VALIDATIONS

12
Responses Validated*

COMPETITORS

46
Responses Validated*

BRANDS

75
Responses Validated*
* Login for a full stack data experience

DATE

APR 2021

TABLES

36

PAGES

112

EDITION

9

PRICE

USD $4950


  

HIGHLIGHTS

Amid the COVID-19 crisis, the global market for NDDS in Cancer Therapy estimated at US$7.3 Billion in the year 2020, is projected to reach a revised size of US$25.5 Billion by 2027, growing at aCAGR of 19.7% over the period 2020-2027. Embolization Particles, one of the segments analyzed in the report, is projected to record 21% CAGR and reach US$1.9 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Nanoparticles segment is readjusted to a revised 19.6% CAGR for the next 7-year period.
The NDDS in Cancer Therapy market in the U.S. is estimated at US$2.2 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$4.5 Billion by the year 2027 trailing a CAGR of 19.3% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 17.5% and 16.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 13.8% CAGR.

SELECT PLAYERS

Celgene Corporation; Galen Limited; Merrimack Pharmaceuticals, Inc.; Samyang Biopharmaceuticals Corp.; Spectrum Pharmaceuticals; Teva Pharmaceutical Industries Ltd.

SEGMENTS

» Segment (Embolization Particles, Nanoparticles)

GEOGRAPHIES

» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World

TABLE OF CONTENTS

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
World Current & Future Analysis for NDDS in Cancer Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for NDDS in Cancer Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2020 & 2027
World Current & Future Analysis for Embolization Particles by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Embolization Particles by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Nanoparticles by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Nanoparticles by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
UNITED STATES
USA Current & Future Analysis for NDDS in Cancer Therapy by Segment - Embolization Particles and Nanoparticles - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
USA 7-Year Perspective for NDDS in Cancer Therapy by Segment - Percentage Breakdown of Value Sales for Embolization Particles and Nanoparticles for the Years 2020 & 2027
CANADA
Canada Current & Future Analysis for NDDS in Cancer Therapy by Segment - Embolization Particles and Nanoparticles - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Canada 7-Year Perspective for NDDS in Cancer Therapy by Segment - Percentage Breakdown of Value Sales for Embolization Particles and Nanoparticles for the Years 2020 & 2027
JAPAN
Japan Current & Future Analysis for NDDS in Cancer Therapy by Segment - Embolization Particles and Nanoparticles - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Japan 7-Year Perspective for NDDS in Cancer Therapy by Segment - Percentage Breakdown of Value Sales for Embolization Particles and Nanoparticles for the Years 2020 & 2027
CHINA
China Current & Future Analysis for NDDS in Cancer Therapy by Segment - Embolization Particles and Nanoparticles - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
China 7-Year Perspective for NDDS in Cancer Therapy by Segment - Percentage Breakdown of Value Sales for Embolization Particles and Nanoparticles for the Years 2020 & 2027
EUROPE
Europe Current & Future Analysis for NDDS in Cancer Therapy by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
Europe 7-Year Perspective for NDDS in Cancer Therapy by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2020 & 2027
Europe Current & Future Analysis for NDDS in Cancer Therapy by Segment - Embolization Particles and Nanoparticles - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Europe 7-Year Perspective for NDDS in Cancer Therapy by Segment - Percentage Breakdown of Value Sales for Embolization Particles and Nanoparticles for the Years 2020 & 2027
FRANCE
France Current & Future Analysis for NDDS in Cancer Therapy by Segment - Embolization Particles and Nanoparticles - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
France 7-Year Perspective for NDDS in Cancer Therapy by Segment - Percentage Breakdown of Value Sales for Embolization Particles and Nanoparticles for the Years 2020 & 2027
GERMANY
Germany Current & Future Analysis for NDDS in Cancer Therapy by Segment - Embolization Particles and Nanoparticles - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Germany 7-Year Perspective for NDDS in Cancer Therapy by Segment - Percentage Breakdown of Value Sales for Embolization Particles and Nanoparticles for the Years 2020 & 2027
ITALY
Italy Current & Future Analysis for NDDS in Cancer Therapy by Segment - Embolization Particles and Nanoparticles - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Italy 7-Year Perspective for NDDS in Cancer Therapy by Segment - Percentage Breakdown of Value Sales for Embolization Particles and Nanoparticles for the Years 2020 & 2027
UNITED KINGDOM
UK Current & Future Analysis for NDDS in Cancer Therapy by Segment - Embolization Particles and Nanoparticles - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UK 7-Year Perspective for NDDS in Cancer Therapy by Segment - Percentage Breakdown of Value Sales for Embolization Particles and Nanoparticles for the Years 2020 & 2027
REST OF EUROPE
Rest of Europe Current & Future Analysis for NDDS in Cancer Therapy by Segment - Embolization Particles and Nanoparticles - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Europe 7-Year Perspective for NDDS in Cancer Therapy by Segment - Percentage Breakdown of Value Sales for Embolization Particles and Nanoparticles for the Years 2020 & 2027
ASIA-PACIFIC
Asia-Pacific Current & Future Analysis for NDDS in Cancer Therapy by Segment - Embolization Particles and Nanoparticles - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Asia-Pacific 7-Year Perspective for NDDS in Cancer Therapy by Segment - Percentage Breakdown of Value Sales for Embolization Particles and Nanoparticles for the Years 2020 & 2027
REST OF WORLD
Rest of World Current & Future Analysis for NDDS in Cancer Therapy by Segment - Embolization Particles and Nanoparticles - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of World 7-Year Perspective for NDDS in Cancer Therapy by Segment - Percentage Breakdown of Value Sales for Embolization Particles and Nanoparticles for the Years 2020 & 2027
Total Companies Profiled: 46

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com